medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2020, Number 2

<< Back Next >>

Rev Latin Infect Pediatr 2020; 33 (2)

Metabolic alterations in human immunodeficiency virus (HIV) infection

González BI, Fortes GS, Arguinzoniz VSL, Arias GE, González SN

Language: Spanish
References: 12
Page: 84-91
PDF size: 241.95 Kb.


ABSTRACT

There are approximately 2.1 million children living with the human immunodeficiency virus (HIV). Highly effective antiviral therapy (HEART) has decreased HIV-related mortality in both children and adults. What was once a progressive and fatal infection is now a chronic disease with a longer life expectancy. Direct damage from HIV, chronic inflammation, premature aging of the immune system, co-infections, HEART and lifestyle can cause different systemic disorders. Children with HIV has been preseting multiple endocrine disorders due to longer time of exposure to the virus, more aggressive treatment and longer survival. This article mentions the main metabolic disorders associated with HIV and the importance of its detection in the pediatric population.


REFERENCES

  1. Siberry GK. Preventing and managing HIV infection in infants, children, and adolescents in the United States. Pediatr Rev. 2014; 35: 268-286.

  2. Rockstroh J, Guaraldi G, Deray G. HIV and the body: a review of multidisciplinary management. HIV Med. 2010; 11 (2): 1-8.

  3. Sokalski KM, Chu J, Mai AY, Qui AQ, Albert AYK, Zanet DAL et al. Endocrine abnormalities in HIV-infected women are associated with peak viral load-the children and women: antiretrovirals and markers of aging (CARMA) cohort. Clinical Endocrinology. 2016; 84: 452-462.

  4. Loomba-Albrecht LA, Bregman T, Chantry CJ. Endocrinopathies in children infected with human immunodeficiency virus. Endocrinol Metab Clin North Am. 214; 43: 807-828.

  5. Kibirige D, Ssekitoleko R. Endocrine and metabolic abnormalities among HIV-infected patients: A current review. Int J STD AIDS. 2013; 28 (8): 603-611.

  6. Lake JE, Currier JS. Metabolic disease in HIV infection. Lancet Infect Dis. 2013; 13: 964-975.

  7. López P, Rubiano LC, Cortés CA, Valencia A, Ramirez O, Sierra A et al. Alteraciones metabólicas con terapia antirretroviral altamente efectiva en niños positivos para VIH, Cali, Colombia. Infectio. 2009; 13 (4): 282-292.

  8. Mehta R, Loredo B, Sañudo ME, Hernández JS, Rodríguez CS, Gómez PF et al. Epidemiología de las anormalidades metabólicas en pacientes con infección por VIH. Rev Invest Clin. 2004; 56 (2): 209-221.

  9. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. USA: AIDS info; 2017. Disponible en: http://aidsinfo.nih.gov/ contentfiles/lvguidelines/pediatricguidelines.pdf.

  10. Jallow A, Ljunggren G, Wändell P, Carlsson AC. Prevalence, incidence, mortality and co-morbidities amongst human immunodeficiency virus (HIV) patients in Stockholm County, Sweden – The Greater Stockholm HIV Cohort Study. AIDS Care. 2015; 27 (2): 142-149.

  11. Rosso R, Parodi A, d’Annunzio G, Ginocchio F, Nicolini L, Torrisi C, Sormani MP, Lorini R, Viscoli C, Vignolo M. Evaluation of insulin resistance in a cohort of HIV-infected youth. European Journal of Endocrinology. 2007; 157: 655- 659.

  12. Chiarelli F, Verrotti A, Galli L, Basciani F, de Martino M. Endocrine dysfunction in children with HIV-1 Infection. J Pediatr Endocrinol Metab. 1999; 12: 17-26.




2020     |     www.medigraphic.com